C
리센스메디컬
394420KOSDAQ의료용 기기 제조업42.9 / 100
Reference Date: 2026-07-24
Financial Score12.5 / 40
News Sentiment18.4 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 44.2% over the past month, and news sentiment is positive.
Company InformationBased on 2025 Annual Report
Business Overview
License Medical develops innovative medical devices through the FDA De Novo process and specializes in regulatory evaluation for retinal and diagnostic medical devices. The company leverages cryogenic cooling technology and transdermal drug delivery systems to create advanced solutions for ophthalmic conditions such as macular degeneration and diabetic retinopathy.
Number of Employees
55people
Average Salary
54.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 20.044.0Point
PBR
18.81Industry Average 1.140.0Point
16.5x industry avg (risky)
ROE
—Industry Average 8.003.5Point
Debt Ratio
27.41Industry Average 11.650.0Point
2.4x industry avg (risky)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
8 totalPositive 5Neutral 2Negative 1Average Sentiment Score 73.8
- PositiveKB증권, 상반기 영업이익 1조 돌파…전년 대비 138% 성장
KB증권의 상반기 영업이익 1조 돌파로 리센스메디컬과 직접적인 연관성이 없으나, 금융업계 전반의 성장이 긍정적 영향을 미칠 것으로 예상.
- PositiveKB증권, 상반기 순이익 8010억…증시 훈풍에 '역대 최대'
KB증권의 상반기 역대 최대 순이익 달성은 리센스메디컬과 관련된 시장 훈풍과 긍정적인 영향을 반영합니다.
- Neutral
Detailed Momentum
52-week position1.0Point
Near 52w low (3%, downtrend)
Current 12,000Won52-week high 33,90052-week low 11,280
1-month return0.0Point
1m -44.19% (strong drop)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral[기재정정]사업보고서 (2025.12)2026-07-09
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30